Science Explorer Back to mapMap
Discussion
Researcher · Anshan Hospital · China

Qing Leng

Qing Leng publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research and Chronic Myeloid Leukemia Treatments.

OpenAlex
World rank
#4,698,947
of 7,710,434 ranked researchers
Rank in China
#712,312
of 978,568
Works
15
Citations
39
Citations per work
2.6
h-index
3
i10-index 2Top 96% in Hematology
Qing Leng

What does Qing Leng research?

Qing Leng's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 9 works · 60.8% of their workMedicine: 9 works · 60.8% of their workHematology: 4 works · 28.3% of their workGenetics: 2 works · 13.0% of their workPathology and Forensic Medicine: 1 works · 6.5% of their workPublic Health, Environmental and Occupational Health: 1 works · 6.5% of their workRheumatology: 1 works · 6.5% of their workEverything else: 4 works · 28.3% of their workLife Sciences: 2 works · 10.9% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 10.9% of their workMolecular Biology: 2 works · 10.9% of their workTHEIR WORKQing Leng15works
Life Sciences11%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine960.8%
  2. Everything else428.3%
    1. Biochemistry, Genetics and Molecular Biology210.9%
  1. 1Hematology28% of their works
  2. 2Genetics13% of their works
  3. 3Molecular Biology11% of their works
  4. 4Public Health, Environmental and Occupational Health6% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Rheumatology6% of their works

Research topics

Which keywords describe Qing Leng's research?

The keywords of their largest research topics: Rituximab, Diagnosis Criteria, International Myeloma Working Group, BCR-ABL, Chronic Lymphocytic Leukemia, Classification, Genomic Aberrations and Imatinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Rituximab72 topics
  2. Diagnosis Criteria61 topic
  3. International Myeloma Working Group61 topic
  4. BCR-ABL51 topic
  5. Chronic Lymphocytic Leukemia51 topic
  6. Classification52 topics
  7. Genomic Aberrations51 topic
  8. Imatinib51 topic
  9. Fusion Genes31 topic
  10. Hypereosinophilic Syndrome31 topic
  11. Adaptive Designs21 topic
  12. Chemotherapy-Induced Peripheral Neuropathy21 topic
  13. False Discovery Rate21 topic
  14. Lymphoma21 topic
  15. Molecular Profiling21 topic
  16. Primary CNS Lymphoma21 topic
  17. Prognostic Scoring System21 topic
  18. Taxanes21 topic

Where does Qing Leng work?

Qing Leng's main affiliation in the publication record is Anshan Hospital, China.

How many publications and citations does Qing Leng have?

OpenAlex counts 15 works and 39 citations for Qing Leng, an h-index of 3, ranking #4,698,947 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Qing Leng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.